Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Niggemann

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
Allergy|September 3, 2017
Hen's egg allergen in house and bed dust is significantly increased after hen's egg consumption-A pilot studyV Trendelenburg, S Tschirner, B Niggemann, et al.
Mediators of Inflammation|January 1, 1995
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infectionB Niggemann, T Stiller, K Magdorf, et al.
Allergy|February 1, 1994
Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic childrenB Niggemann, I Kleinau, M Schmitt, et al.
Allergy|January 1, 1993
Monitoring of inflammation during challenge tests in childrenU Wahn, B Niggemann, I Kleinau, et al.
Lancet (London, England)|May 21, 1999
Low 1-year prevalence of atopic eczema in very low birthweight infantsC Bührer, I Grimmer, B Niggemann, et al.
Journal of Pediatric Surgery|October 5, 2001
Latex allergy in pediatric surgery is dependent on repeated operations in the first year of lifeP Degenhardt, S Golla, F Wahn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 2014
Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challengeB Ahrens, B Niggemann, U Wahn, et al.
Allergy|June 19, 2007
Effect of freezing foods for the outcome of skin prick testsM Ziegert, K Beyer, U Wahn, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic?B Niggemann, D Buck, T Michael, et al.
Acta Endocrinologica. Supplementum|January 1, 1986
Urinary arginine-vasopressin (AVP) excretion in cystic fibrosis (CF)H Stegner, S Caspers, B Niggemann, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Allergy|September 3, 2017
Hen's egg allergen in house and bed dust is significantly increased after hen's egg consumption-A pilot studyV Trendelenburg, S Tschirner, B Niggemann, et al.
Mediators of Inflammation|January 1, 1995
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infectionB Niggemann, T Stiller, K Magdorf, et al.
Allergy|February 1, 1994
Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic childrenB Niggemann, I Kleinau, M Schmitt, et al.
Allergy|January 1, 1993
Monitoring of inflammation during challenge tests in childrenU Wahn, B Niggemann, I Kleinau, et al.
Lancet (London, England)|May 21, 1999
Low 1-year prevalence of atopic eczema in very low birthweight infantsC Bührer, I Grimmer, B Niggemann, et al.
Journal of Pediatric Surgery|October 5, 2001
Latex allergy in pediatric surgery is dependent on repeated operations in the first year of lifeP Degenhardt, S Golla, F Wahn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 2014
Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challengeB Ahrens, B Niggemann, U Wahn, et al.
Allergy|June 19, 2007
Effect of freezing foods for the outcome of skin prick testsM Ziegert, K Beyer, U Wahn, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic?B Niggemann, D Buck, T Michael, et al.
Acta Endocrinologica. Supplementum|January 1, 1986
Urinary arginine-vasopressin (AVP) excretion in cystic fibrosis (CF)H Stegner, S Caspers, B Niggemann, et al.
Pageof 24